These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 12811208)

  • 1. Treatment of ulcerative colitis using fecal bacteriotherapy.
    Borody TJ; Warren EF; Leis S; Surace R; Ashman O
    J Clin Gastroenterol; 2003 Jul; 37(1):42-7. PubMed ID: 12811208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis.
    Yoshimatsu Y; Yamada A; Furukawa R; Sono K; Osamura A; Nakamura K; Aoki H; Tsuda Y; Hosoe N; Takada N; Suzuki Y
    World J Gastroenterol; 2015 May; 21(19):5985-94. PubMed ID: 26019464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis.
    Damman CJ; Brittnacher MJ; Westerhoff M; Hayden HS; Radey M; Hager KR; Marquis SR; Miller SI; Zisman TL
    PLoS One; 2015; 10(8):e0133925. PubMed ID: 26288277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.
    Chen WX; Ren LH; Shi RH
    World J Gastroenterol; 2014 Nov; 20(42):15657-63. PubMed ID: 25400449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis.
    Kump PK; Gröchenig HP; Lackner S; Trajanoski S; Reicht G; Hoffmann KM; Deutschmann A; Wenzl HH; Petritsch W; Krejs GJ; Gorkiewicz G; Högenauer C
    Inflamm Bowel Dis; 2013 Sep; 19(10):2155-65. PubMed ID: 23899544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriotherapy using fecal flora: toying with human motions.
    Borody TJ; Warren EF; Leis SM; Surace R; Ashman O; Siarakas S
    J Clin Gastroenterol; 2004 Jul; 38(6):475-83. PubMed ID: 15220681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis.
    Kunde S; Pham A; Bonczyk S; Crumb T; Duba M; Conrad H; Cloney D; Kugathasan S
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):597-601. PubMed ID: 23542823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.
    Venturi A; Gionchetti P; Rizzello F; Johansson R; Zucconi E; Brigidi P; Matteuzzi D; Campieri M
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1103-8. PubMed ID: 10468688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of probiotics on serum bile acids in patients with ulcerative colitis.
    Sato S; Nagai H; Igarashi Y
    Hepatogastroenterology; 2012 Sep; 59(118):1804-8. PubMed ID: 22369744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
    Kahn SA; Gorawara-Bhat R; Rubin DT
    Inflamm Bowel Dis; 2012 Apr; 18(4):676-84. PubMed ID: 21618362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a Model Culture System of Human Colonic Microbiota to Detect Decreased Lachnospiraceae Abundance and Butyrogenesis in the Feces of Ulcerative Colitis Patients.
    Sasaki K; Inoue J; Sasaki D; Hoshi N; Shirai T; Fukuda I; Azuma T; Kondo A; Osawa R
    Biotechnol J; 2019 May; 14(5):e1800555. PubMed ID: 30791234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
    Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
    J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy.
    Tsuda Y; Yoshimatsu Y; Aoki H; Nakamura K; Irie M; Fukuda K; Hosoe N; Takada N; Shirai K; Suzuki Y
    Scand J Gastroenterol; 2007 Nov; 42(11):1306-11. PubMed ID: 17852859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbial transplant via nasogastric tube for active pediatric ulcerative colitis.
    Suskind DL; Singh N; Nielson H; Wahbeh G
    J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):27-9. PubMed ID: 25162366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A pilot study of treating ulcerative colitis with fecal microbiota transplantation].
    Ren R; Sun G; Yang Y; Peng L; Zhang X; Wang S; Dou Y; Zhang X; Wang Z; Bo X; Liu Q; Li W; Fan N; Ma X
    Zhonghua Nei Ke Za Zhi; 2015 May; 54(5):411-5. PubMed ID: 26080819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study.
    Ishikawa H; Matsumoto S; Ohashi Y; Imaoka A; Setoyama H; Umesaki Y; Tanaka R; Otani T
    Digestion; 2011; 84(2):128-33. PubMed ID: 21525768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients.
    Takeshita K; Mizuno S; Mikami Y; Sujino T; Saigusa K; Matsuoka K; Naganuma M; Sato T; Takada T; Tsuji H; Kushiro A; Nomoto K; Kanai T
    Inflamm Bowel Dis; 2016 Dec; 22(12):2802-2810. PubMed ID: 27824645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora.
    Swidsinski A; Loening-Baucke V; Vaneechoutte M; Doerffel Y
    Inflamm Bowel Dis; 2008 Feb; 14(2):147-61. PubMed ID: 18050295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.